AST SpaceMobile (ASTS) and Ultragenyx Pharmaceutical (RARE) are experiencing unusually high options trading volume today, signaling notable market interest. ASTS options volume reached 74,320 contracts, representing 62.7% of its average daily stock trading volume, with significant activity in the November 2025 $58 put options. Similarly, RARE saw 8,538 options contracts traded, equivalent to 60.4% of its average daily stock volume, highlighted by high interest in the January 2026 $50 call options, indicating targeted speculative or hedging positions around these specific price levels and expirations.
AST SpaceMobile (ASTS) and Ultragenyx Pharmaceutical (RARE) are exhibiting unusually high options trading volumes today, signaling significant market interest. ASTS recorded 74,320 contracts, representing 62.7% of its average daily stock volume, while RARE saw 8,538 contracts, equivalent to 60.4% of its average daily stock volume. This elevated derivatives activity suggests active positioning by institutional or sophisticated investors. Specifically, ASTS experienced substantial volume in the November 14, 2025, $58 strike put option, with 8,640 contracts traded, indicating potential bearish sentiment or hedging against downside risk at that level. For RARE, the January 16, 2026, $50 strike call option saw significant activity with 2,741 contracts, suggesting bullish speculation or positioning for upside. The high options-to-stock volume ratio underscores the use of derivatives for expressing targeted, longer-term views or managing risk exposure. Despite this concentrated activity, the overall sentiment for both tickers remains neutral, implying a balanced distribution of bullish and bearish bets or a mix of speculative and hedging strategies. This dynamic warrants close observation for future price action.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
